Semiconductors
Compare Stocks
5 / 10Stock Comparison
UCTT vs ICHR vs MKSI vs AZTA vs ENTG
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Hardware, Equipment & Parts
Medical - Instruments & Supplies
Semiconductors
UCTT vs ICHR vs MKSI vs AZTA vs ENTG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Hardware, Equipment & Parts | Medical - Instruments & Supplies | Semiconductors |
| Market Cap | $3.63B | $2.47B | $20.25B | $855M | $22.48B |
| Revenue (TTM) | $2.07B | $959M | $4.07B | $597M | $3.24B |
| Net Income (TTM) | $-194M | $-51M | $327M | $-178M | $265M |
| Gross Margin | 15.6% | 11.3% | 45.2% | 44.6% | 43.2% |
| Operating Margin | -5.3% | -3.8% | 14.8% | -26.4% | 29.1% |
| Forward P/E | 34.4x | 62.2x | 30.4x | 23.7x | 41.4x |
| Total Debt | $810M | $186M | $4.69B | $111M | $3.89B |
| Cash & Equiv. | $312M | $98M | $675M | $280M | $360M |
UCTT vs ICHR vs MKSI vs AZTA vs ENTG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ultra Clean Holding… (UCTT) | 100 | 385.4 | +285.4% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 313.1 | +213.1% |
| MKS Inc. (MKSI) | 100 | 284.8 | +184.8% |
| Azenta, Inc. (AZTA) | 100 | 46.5 | -53.5% |
| Entegris, Inc. (ENTG) | 100 | 246.6 | +146.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UCTT vs ICHR vs MKSI vs AZTA vs ENTG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
UCTT is the clearest fit if your priority is long-term compounding.
- 13.9% 10Y total return vs MKSI's 7.5%
ICHR has the current edge in this matchup, primarily because of its strength in growth and momentum.
- 11.6% revenue growth vs UCTT's -2.1%
- +329.1% vs AZTA's -26.5%
MKSI is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 0 yrs, beta 2.64, yield 0.3%
- Rev growth 9.6%, EPS growth 55.5%, 3Y rev CAGR 3.5%
- 0.3% yield, vs ENTG's 0.3%, (3 stocks pay no dividend)
- 3.7% ROA vs UCTT's -11.0%, ROIC 6.5% vs 2.6%
AZTA ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 2.17, Low D/E 6.4%, current ratio 2.98x
- Lower P/E (23.7x vs 41.4x)
- Beta 2.17 vs ICHR's 3.93, lower leverage
ENTG is the clearest fit if your priority is defensive.
- Beta 2.66, yield 0.3%, current ratio 3.35x
- 8.2% margin vs AZTA's -29.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.6% revenue growth vs UCTT's -2.1% | |
| Value | Lower P/E (23.7x vs 41.4x) | |
| Quality / Margins | 8.2% margin vs AZTA's -29.9% | |
| Stability / Safety | Beta 2.17 vs ICHR's 3.93, lower leverage | |
| Dividends | 0.3% yield, vs ENTG's 0.3%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +329.1% vs AZTA's -26.5% | |
| Efficiency (ROA) | 3.7% ROA vs UCTT's -11.0%, ROIC 6.5% vs 2.6% |
UCTT vs ICHR vs MKSI vs AZTA vs ENTG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
UCTT vs ICHR vs MKSI vs AZTA vs ENTG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AZTA leads in 1 of 6 categories
MKSI leads 1 • UCTT leads 0 • ICHR leads 0 • ENTG leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MKSI and ENTG each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MKSI is the larger business by revenue, generating $4.1B annually — 6.8x AZTA's $597M. ENTG is the more profitable business, keeping 8.2% of every revenue dollar as net income compared to AZTA's -29.9%. On growth, MKSI holds the edge at +15.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.1B | $959M | $4.1B | $597M | $3.2B |
| EBITDAEarnings before interest/tax | -$52M | -$11M | $945M | -$115M | $1.3B |
| Net IncomeAfter-tax profit | -$194M | -$51M | $327M | -$178M | $265M |
| Free Cash FlowCash after capex | -$44M | -$17M | $401M | $29M | $721M |
| Gross MarginGross profit ÷ Revenue | +15.6% | +11.3% | +45.2% | +44.6% | +43.2% |
| Operating MarginEBIT ÷ Revenue | -5.3% | -3.8% | +14.8% | -26.4% | +29.1% |
| Net MarginNet income ÷ Revenue | -9.4% | -5.3% | +8.0% | -29.9% | +8.2% |
| FCF MarginFCF ÷ Revenue | -2.1% | -1.7% | +9.8% | +4.8% | +22.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | +4.7% | +15.2% | +1.0% | +5.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.6% | +46.2% | +53.2% | -3.0% | +46.3% |
Valuation Metrics
AZTA leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 68.8x trailing earnings, MKSI trades at a 28% valuation discount to ENTG's 95.3x P/E. On an enterprise value basis, AZTA's 13.8x EV/EBITDA is more attractive than UCTT's 34.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.6B | $2.5B | $20.2B | $855M | $22.5B |
| Enterprise ValueMkt cap + debt − cash | $4.1B | $2.6B | $24.3B | $687M | $26.0B |
| Trailing P/EPrice ÷ TTM EPS | -19.98x | -46.25x | 68.83x | -15.22x | 95.26x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.44x | 62.25x | 30.36x | 23.68x | 41.38x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 34.53x | — | 26.70x | 13.75x | 19.81x |
| Price / SalesMarket cap ÷ Revenue | 1.77x | 2.61x | 5.15x | 1.44x | 7.03x |
| Price / BookPrice ÷ Book value/share | 4.62x | 3.67x | 7.49x | 0.49x | 5.68x |
| Price / FCFMarket cap ÷ FCF | 247.26x | — | 40.74x | 22.32x | 56.74x |
Profitability & Efficiency
Evenly matched — MKSI and AZTA each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
MKSI delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-25 for UCTT. AZTA carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), MKSI scores 6/9 vs ICHR's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -25.4% | -7.5% | +12.2% | -10.7% | +6.7% |
| ROA (TTM)Return on assets | -11.0% | -5.2% | +3.7% | -8.8% | +3.1% |
| ROICReturn on invested capital | +2.6% | -3.9% | +6.5% | -0.5% | +9.3% |
| ROCEReturn on capital employed | +2.9% | -4.7% | +7.2% | -0.6% | +11.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.03x | 0.28x | 1.73x | 0.06x | 0.98x |
| Net DebtTotal debt minus cash | $499M | $87M | $4.0B | -$169M | $3.5B |
| Cash & Equiv.Liquid assets | $312M | $98M | $675M | $280M | $360M |
| Total DebtShort + long-term debt | $810M | $186M | $4.7B | $111M | $3.9B |
| Interest CoverageEBIT ÷ Interest expense | -5.80x | -5.97x | 2.84x | — | 2.47x |
Total Returns (Dividends Reinvested)
MKSI leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MKSI five years ago would be worth $16,648 today (with dividends reinvested), compared to $1,903 for AZTA. Over the past 12 months, ICHR leads with a +329.1% total return vs AZTA's -26.5%. The 3-year compound annual growth rate (CAGR) favors MKSI at 54.1% vs AZTA's -25.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +192.5% | +249.0% | +78.8% | -44.4% | +65.1% |
| 1-Year ReturnPast 12 months | +312.7% | +329.1% | +306.1% | -26.5% | +88.9% |
| 3-Year ReturnCumulative with dividends | +187.5% | +151.1% | +266.0% | -59.1% | +87.4% |
| 5-Year ReturnCumulative with dividends | +59.4% | +28.9% | +66.5% | -81.0% | +30.4% |
| 10-Year ReturnCumulative with dividends | +1385.1% | +629.1% | +750.6% | +123.4% | +1040.3% |
| CAGR (3Y)Annualised 3-year return | +42.2% | +35.9% | +54.1% | -25.8% | +23.3% |
Risk & Volatility
Evenly matched — ICHR and AZTA each lead in 1 of 2 comparable metrics.
Risk & Volatility
AZTA is the less volatile stock with a 2.17 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 97.7% from its 52-week high vs AZTA's 44.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.19x | 3.93x | 2.64x | 2.17x | 2.66x |
| 52-Week HighHighest price in past year | $87.68 | $72.87 | $326.83 | $41.73 | $159.15 |
| 52-Week LowLowest price in past year | $18.52 | $13.12 | $71.49 | $17.11 | $66.32 |
| % of 52W HighCurrent price vs 52-week peak | +91.1% | +97.7% | +92.0% | +44.5% | +92.8% |
| RSI (14)Momentum oscillator 0–100 | 62.3 | 66.9 | 65.3 | 31.1 | 63.8 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 795K | 1.2M | 1.0M | 2.4M |
Analyst Outlook
Evenly matched — MKSI and ENTG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: UCTT as "Buy", ICHR as "Buy", MKSI as "Buy", AZTA as "Buy", ENTG as "Buy". Consensus price targets imply 140.5% upside for AZTA (target: $45) vs -30.1% for ICHR (target: $50). For income investors, MKSI offers the higher dividend yield at 0.29% vs ENTG's 0.27%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $85.00 | $49.80 | $272.86 | $44.67 | $152.00 |
| # AnalystsCovering analysts | 12 | 14 | 29 | 12 | 26 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.3% | — | +0.3% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 0 | 0 | 2 |
| Dividend / ShareAnnual DPS | — | — | $0.87 | — | $0.40 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +0.2% | 0.0% | 0.0% |
AZTA leads in 1 of 6 categories (Valuation Metrics). MKSI leads in 1 (Total Returns). 4 tied.
UCTT vs ICHR vs MKSI vs AZTA vs ENTG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is UCTT or ICHR or MKSI or AZTA or ENTG a better buy right now?
For growth investors, Ichor Holdings, Ltd.
(ICHR) is the stronger pick with 11. 6% revenue growth year-over-year, versus -2. 1% for Ultra Clean Holdings, Inc. (UCTT). MKS Inc. (MKSI) offers the better valuation at 68. 8x trailing P/E (30. 4x forward), making it the more compelling value choice. Analysts rate Ultra Clean Holdings, Inc. (UCTT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UCTT or ICHR or MKSI or AZTA or ENTG?
On trailing P/E, MKS Inc.
(MKSI) is the cheapest at 68. 8x versus Entegris, Inc. at 95. 3x. On forward P/E, Azenta, Inc. is actually cheaper at 23. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — UCTT or ICHR or MKSI or AZTA or ENTG?
Over the past 5 years, MKS Inc.
(MKSI) delivered a total return of +66. 5%, compared to -81. 0% for Azenta, Inc. (AZTA). Over 10 years, the gap is even starker: UCTT returned +1385% versus AZTA's +123. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UCTT or ICHR or MKSI or AZTA or ENTG?
By beta (market sensitivity over 5 years), Azenta, Inc.
(AZTA) is the lower-risk stock at 2. 17β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 81% more volatile than AZTA relative to the S&P 500. On balance sheet safety, Azenta, Inc. (AZTA) carries a lower debt/equity ratio of 6% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — UCTT or ICHR or MKSI or AZTA or ENTG?
By revenue growth (latest reported year), Ichor Holdings, Ltd.
(ICHR) is pulling ahead at 11. 6% versus -2. 1% for Ultra Clean Holdings, Inc. (UCTT). On earnings-per-share growth, the picture is similar: Azenta, Inc. grew EPS 60. 5% year-over-year, compared to -869. 2% for Ultra Clean Holdings, Inc.. Over a 3-year CAGR, MKSI leads at 3. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UCTT or ICHR or MKSI or AZTA or ENTG?
MKS Inc.
(MKSI) is the more profitable company, earning 7. 5% net margin versus -9. 4% for Azenta, Inc. — meaning it keeps 7. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ENTG leads at 28. 9% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — AZTA leads at 45. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UCTT or ICHR or MKSI or AZTA or ENTG more undervalued right now?
On forward earnings alone, Azenta, Inc.
(AZTA) trades at 23. 7x forward P/E versus 62. 2x for Ichor Holdings, Ltd. — 38. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AZTA: 140. 5% to $44. 67.
08Which pays a better dividend — UCTT or ICHR or MKSI or AZTA or ENTG?
In this comparison, MKSI (0.
3% yield), ENTG (0. 3% yield) pay a dividend. UCTT, ICHR, AZTA do not pay a meaningful dividend and should not be held primarily for income.
09Is UCTT or ICHR or MKSI or AZTA or ENTG better for a retirement portfolio?
For long-horizon retirement investors, Ultra Clean Holdings, Inc.
(UCTT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1385% 10Y return). Azenta, Inc. (AZTA) carries a higher beta of 2. 17 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UCTT: +1385%, AZTA: +123. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UCTT and ICHR and MKSI and AZTA and ENTG?
These companies operate in different sectors (UCTT (Technology) and ICHR (Technology) and MKSI (Technology) and AZTA (Healthcare) and ENTG (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.